2Paul J. Bioterrorism and biodefence. J Infect, 2002; 44 (1): 59-66
3Smith H. Discovery ofthe anthrax toxin: the beginning of studies of virulence determinants regulated in vivo. Int J Med Mircrobiol, 2002; 291(6～7): 411～417
4Inglesby TV, Henderson DA, Bartlett JG, et al. Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA, 1999; 281 (18): 1735～1745
5Mourez M, Kane RS, Mogridge J, et al. Designing a polyvalent inhibitor of anthrax toxin. Nat Biotechnol, 2001; 19 (10): 958～961
6Bradley KA, Mogridge J, Mourez M, etal. Identification of the cellular receptor for anthrax toxin. Nature, 2001; 414 (8): 225～229
7Zhou B, Wirsching P, Janda KD. Human antibodies against spores of the genus Bacillus: A model study for detection of and protection against anthrax and the bioterrorist threat. Proc Natl Acad Sci U S A, 2002; 99(8): 5241 ～ 5246
8Chaudry Gj, Moayeri M, Liu S, et al. Quickening the pace of anthraxresearch: three advances point towards possible therapies. Trends Microbiol, 2002; 10 (2): 58～62
9Collier RJ. Mechanism of membrane translocation by anthrax toxin: insertion and pore formation by protective antigen. J Appl Mircrobiol,1999; 87 (2): 283
10Sellman BR, Mourez M, Collier J. Dominant- negative mutants of a toxin subunit: a approach to therapy of anthrax. Science, 2001; 292:695 ～ 697
